Perinatal Asphyxia and Therapeutic Hypothermia: Best Practices
Perinatal asphyxia describes impaired oxygen delivery or blood flow around birth that can injure several organs, especially the brain. When this injury produces evolving neurological dysfunction, it is commonly described as hypoxic-ischemic encephalopathy (HIE). The clinical range is broad: some newborns recover quickly after effective resuscitation, while others develop seizures, abnormal tone, or multisystem failure requiring intensive care.
Therapeutic hypothermia has become a central treatment for carefully selected term and near-term infants with moderate-to-severe HIE. Cooling does not reverse the initial insult, but it can reduce secondary cellular injury when started promptly and delivered within a structured neonatal intensive care pathway. Best practice therefore depends on more than placing an infant on a cooling device; it requires coordinated assessment, safe transport, continuous monitoring, and long-term developmental follow-up.
The subject was highly relevant to the scientific focus of FAOPS 2020 and PREBIC AA 2020, meetings intended to bring perinatal and neonatal specialists together in Tokyo. Although the congress was canceled in April 2020 because of the COVID-19 pandemic and international travel difficulties, the clinical priorities remain current: rapid recognition, consistent protocols, family communication, and equitable access to specialist care.
Recognizing Hypoxic-Ischemic Injury
The first step is identifying an infant who may have experienced significant intrapartum or immediate postnatal compromise. Important clues include a sentinel event such as placental abruption, uterine rupture, cord prolapse, severe fetal bradycardia, or prolonged maternal hypotension. Low Apgar scores, the need for prolonged ventilation, and cord or early blood gas results showing metabolic acidosis add support, but no single finding establishes the diagnosis.
Neurological examination is central. Clinicians assess consciousness, spontaneous activity, posture, muscle tone, primitive reflexes, respiratory effort, and the presence of seizures. Moderate encephalopathy may involve lethargy, hypotonia, weak suck, an incomplete Moro response, or an abnormal respiratory pattern. Severe disease can include stupor, flaccidity, absent reflexes, apnea, and electrographic seizures. Because signs evolve during the first hours, repeated examinations are essential.
Eligibility for cooling generally combines evidence of significant perinatal hypoxia-ischemia with moderate or severe encephalopathy. Gestational age, birth weight, timing, congenital anomalies, uncontrolled bleeding, and the infant’s overall condition must also be considered. Local protocols should define thresholds and escalation pathways, while specialist consultation helps address borderline presentations.
Stabilizing the Infant Before Cooling
Resuscitation follows neonatal life-support principles. The immediate priorities are effective ventilation, adequate circulation, correction of severe hypoglycemia, and treatment of major electrolyte or metabolic abnormalities. Excessive oxygen exposure should be avoided, while oxygenation and carbon dioxide are maintained within appropriate ranges. Hypotension, acidosis, anemia, and seizures can intensify secondary brain injury and need prompt management.
Temperature requires particular attention. An infant being evaluated for HIE should not be actively rewarmed if spontaneous cooling has occurred, but uncontrolled hypothermia is unsafe. Core temperature should be measured continuously with a reliable probe, and clinicians should avoid both hyperthermia and temperatures below the intended treatment range. The goal is controlled whole-body or selective-head cooling, not passive exposure to a cold environment.
Airway protection may be necessary when respiratory drive is poor or seizures compromise ventilation. Blood pressure, urine output, glucose, lactate, renal function, liver enzymes, coagulation, and blood counts provide a picture of multisystem involvement. Infection can mimic or worsen encephalopathy, so cultures and empiric antibiotics may be indicated when clinical risk supports them.
Delivering Controlled Neuroprotection
For eligible infants, cooling should begin as early as possible, ideally within six hours of birth. Most established protocols target a core temperature close to 33–34°C for 72 hours, using a servo-controlled device and continuous rectal or esophageal temperature monitoring. The exact target and method depend on the device and institutional protocol. Manual ice-pack cooling is difficult to control and can cause dangerous temperature fluctuations.
A cooling pathway should define who confirms eligibility, how the infant is transported, which device is used, and when treatment is stopped. Passive cooling during referral may be appropriate under specialist direction, but it requires frequent temperature checks and clear communication with the receiving unit. Delays caused by waiting for every test can reduce the potential benefit of treatment; clinical assessment, blood gas evidence, and neurological findings should be integrated rapidly.
Rewarming is usually gradual after the 72-hour treatment period, often at approximately 0.5°C per hour. Abrupt rewarming can produce hypotension, seizures, and metabolic instability. During and after rewarming, the team continues surveillance for neurological changes, respiratory deterioration, arrhythmias, bleeding, and glucose disturbance. Cooling is an intensive therapy, and its safety depends on disciplined bedside monitoring.
| Clinical area | Best-practice approach | Common risk to avoid |
|---|---|---|
| Eligibility | Combine perinatal history, blood gas or metabolic evidence, gestational age, and serial neurological examination | Treating a single low Apgar score as sufficient |
| Timing | Start controlled cooling as soon as possible, ideally within six hours | Delaying treatment while awaiting nonessential investigations |
| Temperature | Use a servo-controlled device and continuous core-temperature monitoring | Uncontrolled passive cooling or temperature overshoot |
| Duration | Follow a validated protocol, commonly 72 hours for eligible infants | Stopping early without a clinical reason |
| Seizures | Use continuous or prolonged EEG when available and treat electrographic seizures | Relying only on visible movements |
| Rewarming | Increase temperature slowly with ongoing cardiorespiratory monitoring | Rapid rewarming and failure to anticipate instability |
| Follow-up | Arrange neurological, hearing, vision, and developmental surveillance | Discharging without a structured outcome plan |
Monitoring the Brain and Other Organs
Seizures are common after hypoxic-ischemic injury, and many are clinically subtle or entirely electrographic. Amplitude-integrated EEG can support bedside assessment, while conventional continuous EEG provides more complete seizure detection and background evaluation. Monitoring should begin as early as feasible and continue through the period of greatest risk, according to local resources and clinical condition.
Cranial ultrasound may help identify major abnormalities, but magnetic resonance imaging is usually more informative for defining the pattern and extent of brain injury. MRI timing varies with stability and institutional practice; diffusion-weighted sequences are particularly valuable in the early assessment of hypoxic-ischemic injury. Imaging should complement, rather than replace, serial examination and EEG findings.
Cooling affects cardiovascular, respiratory, renal, hepatic, and hematological systems. Bradycardia is expected to some degree, but hypotension, arrhythmia, worsening coagulopathy, thrombocytopenia, oliguria, and pulmonary hypertension require active assessment. Medication clearance can also change during hypothermia, making careful dosing and repeated evaluation important. Pain, agitation, and shivering should be managed without masking clinically meaningful neurological changes more than necessary.
Supporting Families and Continuity of Care
Parents need clear, compassionate explanations about what is known, what remains uncertain, and why cooling is being recommended. A useful conversation covers the suspected birth event, examination findings, treatment window, monitoring plan, possible complications, and the limits of prognostic prediction during the first hours. Families should be included in bedside care where safe, with interpreters used when language barriers exist.
Feeding decisions require individualized planning. Infants with encephalopathy may initially need intravenous fluids or tube feeding because coordination of sucking, swallowing, and breathing is impaired. Expressed breast milk can often be supported when clinically appropriate, and lactation assistance should begin early. For wider maternal and neonatal infection-control considerations, clinicians can also consult this breastfeeding guidance for mothers with suspected or confirmed COVID-19.
Discharge planning starts well before the infant leaves intensive care. Families should receive information about seizure warning signs, feeding problems, tone abnormalities, hearing and vision assessment, and the importance of developmental review. Early intervention services, physiotherapy, occupational therapy, speech and feeding support, and community nursing can reduce delays in care when concerns emerge.
Building Reliable Perinatal Systems
Outcomes depend on the whole perinatal network, not only the specialist unit that provides cooling. Antenatal services, delivery teams, neonatal transport, emergency departments, intensive care clinicians, neurologists, radiologists, nurses, therapists, and follow-up providers need shared criteria and dependable communication. Regular simulation of neonatal resuscitation, cooling initiation, and referral transfer can reveal practical failures before an emergency occurs.
Protocols should include a cooling checklist, temperature documentation, seizure-management guidance, medication references, and clear criteria for contacting a regional HIE center. Quality improvement teams can review time from birth to recognition, time to target temperature, unplanned temperature excursions, EEG availability, complications, mortality, and developmental outcomes. Data should be interpreted with attention to case mix and access to care.
International meetings and professional networks help compare protocols and disseminate research, but service continuity cannot depend on travel. The experience described in the pandemic conference review illustrates why virtual teaching, regional referral agreements, and locally adaptable guidance are valuable additions to traditional congress-based collaboration.
Practical Priorities for Clinical Teams
A concise bedside framework can help teams act consistently when every minute matters. It should support, rather than replace, national neonatal resuscitation guidance and consultation with an experienced neonatologist or regional cooling center.
- Establish a rapid referral and consultation pathway for infants with suspected HIE.
- Use standardized eligibility criteria that combine clinical history, biochemical evidence, and serial neurological examinations.
- Start controlled cooling within the treatment window and document core temperature continuously.
- Provide EEG-based seizure surveillance, comprehensive organ monitoring, and carefully planned rewarming.
- Arrange family-centered discharge planning with developmental follow-up and early intervention access.
Hospitals should audit the pathway from delivery-room recognition through long-term follow-up. Reviewing near misses, delayed transfers, temperature instability, and missed seizures can improve care more effectively than relying on individual memory. Education should include obstetric and transport teams, because the decision to seek specialist help often occurs before the infant reaches intensive care.
Clinicians should translate these principles into a locally approved protocol, rehearse it with the multidisciplinary team, and ensure that families receive consistent information throughout treatment. Prompt recognition, controlled neuroprotection, meticulous monitoring, and sustained follow-up give vulnerable newborns the strongest opportunity for healthy development.
